Capricor Therapeutics Inc (CAPR.OQ)
CAPR.OQ on NASDAQ Stock Exchange Capital Market
0.55USD
13 Dec 2018
0.55USD
13 Dec 2018
Change (% chg)
$-0.01 (-1.18%)
$-0.01 (-1.18%)
Prev Close
$0.55
$0.55
Open
$0.54
$0.54
Day's High
$0.55
$0.55
Day's Low
$0.54
$0.54
Volume
21,523
21,523
Avg. Vol
21,599
21,599
52-wk High
$2.29
$2.29
52-wk Low
$0.51
$0.51
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 0.22 | -0.135 |
| Jun '18 | 0.40 | -0.142 | |
| Mar '18 | 0.40 | -0.136 | |
| FY 2017 | Dec '17 | 0.48 | 0.306 |
| Sep '17 | 0.31 | -0.117 | |
| Jun '17 | 1.00 | -0.157 | |
| Mar '17 | 0.88 | -0.171 | |
| FY 2016 | Dec '16 | 0.91 | -0.211 |
| Sep '16 | 0.75 | -0.292 | |
| Jun '16 | 1.13 | -0.261 | |
| Mar '16 | 1.22 | -0.258 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 2 | 0.12 | 0.23 | 0.00 | -- |
| Year Ending Dec-18 | 2 | 1.16 | 1.30 | 1.02 | 4.10 |
| Year Ending Dec-19 | 2 | 0.65 | 1.30 | 0.00 | 4.10 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 2 | -0.16 | -0.15 | -0.17 | -- |
| Year Ending Dec-18 | 2 | -0.57 | -0.57 | -0.58 | -0.76 |
| Year Ending Dec-19 | 2 | -0.50 | -0.50 | -0.50 | -0.76 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 69.71 | 34.39 | |
| P/E High - Last 5 Yrs. | -- | 148.17 | 46.24 | |
| P/E Low - Last 5 Yrs. | -- | 47.84 | 24.59 | |
| Beta | -2.65 | 1.08 | 0.91 | |
| Price to Sales (TTM) | 19.03 | 49.58 | 6.22 | |
| Price to Book (MRQ) | -- | 10.17 | 5.20 | |
| Price to Tangible Book (MRQ) | -- | 13.83 | 6.74 | |
| Price to Cash Flow (TTM) | -- | 52.85 | 24.17 | |
| % Owned Institutions | 3.23 | 3.75 | 1.78 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.12 | 1.44 | |
| Dividend Yield - 5 Year Avg | -- | 0.09 | 1.46 | |
| Dividend 5 Year Growth Rate | -- | 0.79 | 4.94 | |
| Payout Ratio(TTM) | -- | 7.05 | 42.49 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -11.80 | 130.06 | 8.17 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -26.18 | 47.89 | 6.50 | |
| Sales - 5 Yr. Growth Rate | 24.17 | 22.79 | 10.44 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 39.94 | 75.90 | 23.08 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 8.12 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 12.04 | 10.49 | |
| Capital Spending - 5 Yr. Growth Rate | 149.85 | 9.25 | 14.59 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.18 | 2.28 |
| Current Ratio (MRQ) | 0.82 | 3.44 | 3.10 |
| LT Debt to Equity (MRQ) | -- | 18.69 | 11.49 |
| Total Debt to Equity (MRQ) | -- | 31.36 | 16.03 |
| Interest Coverage (TTM) | -58.74 | -43.32 | 30.57 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 56.37 | 54.44 | |
| Gross Margin - 5 Yr. Avg. | -- | 60.62 | 52.36 | |
| EBITD Margin (TTM) | -423.45 | -- | -- | |
| EBITD - 5 Yr. Avg | -265.04 | -109.98 | 13.16 | |
| Operating Margin (TTM) | -470.06 | -185.00 | 6.07 | |
| Operating Margin - 5 Yr. Avg. | -287.51 | -126.42 | 8.47 | |
| Pre-Tax Margin (TTM) | -481.18 | -175.77 | 7.02 | |
| Pre-Tax Margin - 5 Yr. Avg. | -292.39 | -132.58 | 8.71 | |
| Net Profit Margin (TTM) | -481.18 | -182.51 | 3.12 | |
| Net Profit Margin - 5 Yr. Avg. | -292.39 | -136.98 | 4.91 | |
| Effective Tax Rate (TTM) | -- | 21.47 | 23.26 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 15.43 | 23.83 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 7,649,006 | 873,053,182 | |
| Net Income/Employee (TTM) | -- | 653,334 | 103,483,965 | |
| Receivable Turnover (TTM) | 13.29 | 6.25 | 5.80 | |
| Inventory Turnover (TTM) | -- | 1.89 | 3.56 | |
| Asset Turnover (TTM) | 0.25 | 0.32 | 0.95 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -120.88 | 6.47 | 11.45 | |
| Return on Assets - 5 Yr. Avg. | -96.30 | 5.54 | 12.50 | |
| Return on Investment (TTM) | -645.84 | 9.01 | 14.96 | |
| Return on Investment - 5 Yr. Avg. | -149.85 | 6.87 | 16.23 | |
| Return on Equity (TTM) | -- | 10.15 | 16.52 | |
| Return on Equity - 5 Yr. Avg. | -- | 8.41 | 17.37 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -27.53 | 99.55 | 24.17 |
| EPS (TTM) % | -25.39 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Capricor Therapeutics Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 177.67 | 168.10 | 99 | 98 |
| 13 Week | 326.87 | 306.08 | 99 | 94 |
| 26 Week | -0.69 | -8.24 | 99 | 98 |
| 52 Week | -15.13 | -28.07 | 78 | 68 |
| YTD | 7.52 | -5.58 | 99 | 72 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 7.06% |
| # of Holders: | 24 |
| Total Shares Held: | 2,193,539 |
| 3 Mo. Net Change: | -233,127 |
| # New Positions: | 4 |
| # Closed Positions: | 1 |
| # Increased Positions: | 8 |
| # Reduced Positions: | 6 |
| # Net Buyers: | 2 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.